Kim, Pyunggang
Park, Jinah https://orcid.org/0000-0002-4747-1198
Lee, Dong-Joon https://orcid.org/0000-0001-6532-9729
Mizuno, Seiya
Shinohara, Masahiro
Hong, Chang Pyo
Jeong, Yealeen
Yun, Rebecca
Park, Hyeyeon
Park, Sujin
Yang, Kyung-Min
Lee, Min-Jung
Jang, Seung Pil
Kim, Hyun-Yi
Lee, Seung-Jun https://orcid.org/0000-0003-3198-157X
Song, Sun U.
Park, Kyung-Soon https://orcid.org/0000-0002-0615-4313
Tanaka, Mikako
Ohshima, Hayato https://orcid.org/0000-0001-8571-9900
Cho, Jin Won
Sugiyama, Fumihiro
Takahashi, Satoru https://orcid.org/0000-0002-8540-7760
Jung, Han-Sung https://orcid.org/0000-0003-2795-531X
Kim, Seong-Jin https://orcid.org/0000-0003-4335-8793
Funding for this research was provided by:
National Research Foundation of Korea (NRF-2016R1A5A1010764, NRF-2015M3A9B6073840, 2022R1A2B5B03001627, 2016R1A5A2008630, 2017M3A9E4048172)
GILO Foundation is a non-profit organization that aims to promote basic biomedical researches.
Article History
Received: 19 April 2021
Accepted: 28 June 2022
First Online: 8 July 2022
Competing interests
: The authors declare the following competing interests: S.J.K. has a personal financial interest as a shareholder in Amoris Bio Inc. and TheragenEtex; and declares ownership in Medpacto Inc. J.P. is an employee of Amoris Bio Inc., and C.H. is an employee of TheragenEtex, and K.Y. is an employee of Medpacto Inc. S.S. declares ownership in SCM Lifescience Inc. S.T, S.J.K., and H.J are listed as inventors on the pending patent application(s) on the modulation of MSCs by Mast4 deletion. All other authors declare no competing interests.